A Phase 1 Study of ATV-1601 in Patients With Advanced Cancer That Have AKT1 E17K Mutations
Atavistik Bio, Inc
Atavistik Bio, Inc
BeOne Medicines
Seagen Inc.
Eli Lilly and Company
Tesaro, Inc.
Hoffmann-La Roche
Merck Sharp & Dohme LLC
Hoffmann-La Roche
Genmab
AstraZeneca
Arcus Biosciences, Inc.
USWM, LLC (dba US WorldMeds)
AstraZeneca
AstraZeneca
EMD Serono
USWM, LLC (dba US WorldMeds)
Poseida Therapeutics, Inc.
AstraZeneca
Haihe Biopharma Co., Ltd.
AstraZeneca
Impact Therapeutics, Inc.
Amgen
AstraZeneca
Seagen Inc.
Novartis
Tesaro, Inc.
Takeda
EMD Serono
Verastem, Inc.
AstraZeneca
EMD Serono
NeoTX Therapeutics Ltd.
BicycleTx Limited
TScan Therapeutics, Inc.
BicycleTx Limited
SystImmune Inc.
Gradalis, Inc.
AbbVie
Merck Sharp & Dohme LLC
Pfizer
TCR2 Therapeutics
TCR2 Therapeutics
Oncoinvent Solutions AS
Exelixis
Nuvectis Pharma, Inc.
AstraZeneca
Toray Industries, Inc
Arsenal Biosciences, Inc.
OncoC4, Inc.
Daiichi Sankyo